Nav: Home

Cancer authority pulls together the principles, practice and ethics of cancer care

January 04, 2017

Samuel Hellman, MD, the former Dean of the Division of Biological Sciences and the Pritzker School of Medicine at the University of Chicago, "cannot remember a time when I did not want to become a doctor."

The field of cancer research is glad he felt that calling. Many patients worldwide have benefitted from innovations during his distinguished career in cancer care, research, teaching and administration. The short list of his career highlights includes roles as co-editor of seven editions of the world's leading cancer textbook, former physician-in-chief at the nation's top cancer center, former chairman of radiation therapy at the Harvard Medical School and past president of two of the country's most influential cancer organizations.

Graduating from Allegheny College and SUNY Upstate Medical College, he received postgraduate training at Harvard and Yale, and a fellowship at London's Royal Marsden Hospital. Along the way, he published scores of academic manuscripts, editorials, essays, opinion pieces and reminiscences in an array of high-impact medical journals as well as more general magazines.

Selected publications that are accessible to a general audience, plus a few unpublished pieces, have now been compiled into a book, Learning While Caring: Reflections on a Half-Century of Cancer Practice, Research, Education and Ethics, published in January 2017 by Oxford University Press.

The title, Learning While Caring, is instructive. Physicians have no choice but to continue their professional education while practicing medicine, Hellman argues. "Lifelong learning is essential," he insists, but keeping up with the literature and presenting at meetings must be combined with skills learned more informally through the experience of caring for patients. Much of what is taught in medical school needs to be revised or modified or even discarded throughout the physician's career. "Medicine is a learned profession," he wrote, "but perhaps more important, it is a learning profession."

The book includes three dozen essays and commentaries, presented in five sections - medical ethics and learning, academic medicine, research, perceptions of cancer, and heroes - with each section organized chronologically.

The section on ethics, the longest, focuses on the author's "uneasiness" with the process of randomized clinical trials. In such trials, the immediate interests of a patient may compete with the long-term benefits to society, placing the physician in a position that Hellman describes as "ethically intolerable."

It is a doctor's primary responsibility, Hellman insists, to "act as a patient's agent." This "takes precedence over his responsibility as a scientist."

He also argues that medicine should not be intellectually or physically separate from other academic activities in the university. Patient care draws as much from the humanities and social sciences as from the biological and physical sciences. And a good general education must include some medically related science. "You can't consider genetic engineering of plants or animals, including humans," he insists, "without understanding what a gene is and how it functions."

The section on academic medicine features a humorous interlude, "Tales of the Unnatural," published in JAMA shortly after Halloween in 1998. This essay, should be required reading for up and coming physician-scientists considering leadership roles.

Hellman sets the tone by pointing out that altering just one letter converts the title of dean into dead - a transformation that suggests how the office holder is subsequently perceived by former friends and colleagues. He next describes the hierarchy of the academic nobility. Department chairs and senior faculty, for example are vampires of available resources. Lower ranking faculty, administrators, board members and even donors are all endowed with comparably ghoulish titles.

Although a few of the selections in the section on research contain some scientific or medical jargon, they remain quite readable. Much of this section focuses on the gradual, grudging evolution of breast cancer treatment. Hellman was among the early advocates for replacing radical mastectomies in patients with early-stage disease with much less disfiguring operations - limited tumor removal followed by radiation therapy. Over time, this became the preferred approach.

As part of this crusade, Hellman and his Harvard and University Chicago colleague, Ralph Weichselbaum, coined the term "oligometastasis," referring to an intermediate spectrum of states between confined and widespread disease. Controversial at first, oligometastasis is now generally accepted and has considerable therapeutic importance.

The next section is concerned with the perception of cancer by the general public, the patient and even the different medical specialties and providers. This is affected by is its metaphoric use in western culture. In order for cancer to be properly considered, Hellman stresses, it must be demythologized.

The book ends with Hellman's carefully considered thoughts about two of his medical heroes: Thomas Hodgkin, for whom Hodgkin's disease was named and a model for the scholarly physician; and Marie Curie, who won the Nobel Prize twice, for the discovery of radium, essential for early radiation therapy, and its chemistry. Both were chosen not only for their scientific distinction but also for their involvement in the important affairs of their time.

In a closing summary, Hellman shares some pithy advice, acquired during a 50-year revolution in biology and medicine that brought practical, philosophical, and societal issues with which academia, medicine and cancer care continue to grapple:
  • The strict application of market principles to medicine is not in the best interest of patients, health care professionals or society at large.
  • Medical science is general, but patient care is individual.
  • Beware of mediocrity. There is a great difference between competence and excellence.
  • Love and value what you do, and,
  • Have modesty; don't be too sure!
-end-


University of Chicago Medical Center

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
More Cancer News and Cancer Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab